TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model

Kidney International

Volumn 66, Issue 4, 2004, Pages 1677-1685

  Yoshio, Yoko ^a   Miyazaki, Masanobu ^b   Abe, Katsushige ^b   Nishino, Tomoya ^b   Furusu, Akira ^b   Mizuta, Yohei ^b   Harada, Takashi ^b   Ozono, Yoshiyuki ^b   Koji, Takehiko ^b   Kohno, Shigeru ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Angiogenesis; Dialysis; Inflammation; Myofibroblasts; Peritoneal fibrosis; TNP 470

Indexed keywords

ALPHA ACTIN; ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; CHLORHEXIDINE GLUCONATE; COLLAGEN TYPE 3; CYCLIN DEPENDENT KINASE 2; FUMAGILLOL CHLOROACETYLCARBAMATE; HEAT SHOCK PROTEIN 47; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FIBROSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; MYOFIBROBLAST; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM FIBROSIS; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULARIZATION;

EID: 4644371254     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00935.x     Document Type: Article

References (45)

1. GANDHI VC, HUMAYUN HM, ING TS, et al: Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140:1201-1203, 1980
2. HAUGLUSTAINE D, VAN MEERBEEK J, MONBALLYU J, et al: Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD. Clin Nephrol 22:158-162, 1984
3. NAKAMOTO M: Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes. Perit Dial Int 16(Suppl 1):S39-41, 1996
4. COLES GA, TOPLEY N: Long-term peritoneal membrane changes. Adv Ren Replace Ther 7:289-301, 2000
5. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
6. HONDA K, NITTA K, HORITA S, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
7. COMBET S, MIYATA T, MOULIN P, et al: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717-728, 2000
8. MATEIJSEN MA, VAN DER WAL AC, HENDRIKS PM, et al: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19:517-525, 1999
9. ZWEERS MM, STRUIJK DG, SMIT W, et al: Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow-up. J Lab Clin Med 137:125-132, 2001
10. ZWEERS MM, DE WAART DR, SMIT W, et al: Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134:124-132, 1999
11. FOLKMAN J: Tumor angiogenesis. Adv Cancer Res 43:175-203, 1985
12. D'AMORE PA: Growth factors, angiogenesis and metastasis. Prog Clin Biol Res 212:269-285, 1986
13. SEBAG J, MCMEEL JW: Diabetic retinopathy. Pathogenesis and the role of retina-derived growth factor in angiogenesis. Surv Ophthalmol 30:377-384, 1986
14. SCHRAA AJ, EVERTS M, KOK RJ, et al: Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases. Biotechnol Annu Rev 8:133-165, 2002
15. STRIETER RM, BELPERIO JA, KEANE MP: CXC chemokines in angiogenesis related to pulmonary fibrosis. Chest 122:298S-301S, 2002
16. INGBER D, FUJITA T, KISHIMOTO S, et al: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557, 1990
17. LIEKENS S, VERBEKEN E, VANDEPUTTE M, et al: A novel animal model for hemangiomas: Inhibition of hemangioma development by the angiogenesis inhibitor TNP-470. Cancer Res 59:2376-2383, 1999
18. JOUSSEN AM, BEECKEN WD, MOROMIZATO Y, et al: Inhibition of inflammatory corneal angiogenesis by TNP-470. Invest Ophthalmol Vis Sci 42:2510-2516, 2001
19. OLIVER SJ, BANQUERIGO ML, BRAHN E: Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Immunol 157:291-299, 1994
20. OLIVER SJ, CHENG TP, BANQUERIGO ML, et al: Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF). Cell Immunol 166:196-206, 1995
21. INOUE K, CHIKAZAWA M, FUKATA S, et al: Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. Clin Cancer Res 9:886-899, 2003
22. MIKI T, NONOMURA N, NOZAWA M, et al: Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line. J Urol 160:210-213, 1998
23. MORI S, UEDA T, KURATSU S, et al: Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int J Cancer 61:148-152, 1995
24. SINGH Y, SHIKATA N, KIYOZUKA Y, et al: Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo. Breast Cancer Res Treat 45:15-27, 1997
25. HORI A, IKEYAMA S, SUDO K: Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem Biophys Res Commun 204:1067-1073, 1994
26. KRIA L, OHIRA A, AMEMIYA T: TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: A possible drug therapy for pterygia. Curr Eye Res 17:986-993, 1998
27. OGATA T, KURABAYASHI M, MAENO T, et al: Angiogenesis inhibitor TNP-470 (AGM-1470) suppresses vascular smooth muscle cell proliferation after balloon injury in rats. J Surg Res 112:117-121, 2003
28. WANG YQ, IKEDA K, IKEBE T, et al: Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats. Hepatology 32:980-989, 2000
29. HARAGUCHI M, OKAMURA M, KONISHI M, et al: Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo. Kidney Int 51:1838-1846, 1997
30. MISHIMA Y, MIYAZAKI M, ABE K, et al: Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. Perit Dial Int 23:14-22, 2003
31. NISHINO T, MIYAZAKI M, ABE K, et al: Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int 64:887-896, 2003
32. MARGETTS PJ, GYORFFY S, KOLB M, et al: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728, 2002
33. FIGG WD, PLUDA JM, LUSH RM, et al: The pharmacokinetics of TNP-470, a new angiogenesis inhibitor. Pharmacotherapy 17:91-97, 1997
34. ZHANG Y, GRIFFITH EC, SAGE J, et al: Cell cycle inhibition by the antiangiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci USA 97:6427-6432, 2000
35. GRIFFIOEN AW, MOLEMA G: Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52:237-268, 2000
36. PEACOCK DJ, BANQUERIGO ML, BRAHN E: A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol 160:178-184, 1995
37. ARSENAULT AL, LHOTAK S, HUNTER WL, et al: Taxol involution of collagen-induced arthritis: Ultrastructural correlation with the inhibition of synovitis and neovascularization. Clin Immunol Immunopathol 86:280-289, 1998
38. SOLOWIEJ A, BISWAS P, GRAESSER D, et al: Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 162:953-962, 2003
39. FRIES JW, WILLIAMS AJ, ATKINS RC, et al: Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 143:725-737, 1993
40. PELLETIER RP, OHYE RG, VANBUSKIRK A, et al: Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol 149:2473-2481, 1992
41. IKEDA U, IKEDA M, SEINO Y, et al: Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by proinflammatory cytokines. Atherosclerosis 104:61-68, 1993
42. KULIDJIAN AA, ISSEKUTZ AC, ISSEKUTZ TB: Differential role of E-selectin and P-selectin in T lymphocyte migration to cutaneous inflammatory reactions induced by cytokines. Int Immunol 14:751-760, 2002
43. GABBIANI G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200:500-503, 2003
44. PHAN SH: The myofibroblast in pulmonary fibrosis. Chest 122:286S-289S, 2002
45. NAKAI A, SATOH M, HIRAYOSHI K, et al: Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J Cell Biol 117:903-914, 1992